serw-MX  [xml]  
 


    
 DeCS Categories

C10 Nervous System Diseases .
C10.228 Central Nervous System Diseases .
C10.228.140 Brain Diseases .
C10.228.140.163 Brain Diseases, Metabolic .
C10.228.140.163.100 Brain Diseases, Metabolic, Inborn .
C10.228.140.163.100.435 Lysosomal Storage Diseases, Nervous System .
C10.228.140.163.100.435.340 Glycogen Storage Disease Type II .
C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities .
C16.320 Genetic Diseases, Inborn .
C16.320.565 Metabolism, Inborn Errors .
C16.320.565.189 Brain Diseases, Metabolic, Inborn .
C16.320.565.189.435 Lysosomal Storage Diseases, Nervous System .
C16.320.565.189.435.340 Glycogen Storage Disease Type II .
C16.320.565.202 Carbohydrate Metabolism, Inborn Errors .
C16.320.565.202.449 Glycogen Storage Disease .
C16.320.565.202.449.500 Glycogen Storage Disease Type II .
C16.320.565.595 Lysosomal Storage Diseases .
C16.320.565.595.554 Lysosomal Storage Diseases, Nervous System .
C16.320.565.595.554.340 Glycogen Storage Disease Type II .
C18 Nutritional and Metabolic Diseases .
C18.452 Metabolic Diseases .
C18.452.132 Brain Diseases, Metabolic .
C18.452.132.100 Brain Diseases, Metabolic, Inborn .
C18.452.132.100.435 Lysosomal Storage Diseases, Nervous System .
C18.452.132.100.435.340 Glycogen Storage Disease Type II .
C18.452.648 Metabolism, Inborn Errors .
C18.452.648.189 Brain Diseases, Metabolic, Inborn .
C18.452.648.189.435 Lysosomal Storage Diseases, Nervous System .
C18.452.648.189.435.340 Glycogen Storage Disease Type II .
C18.452.648.202 Carbohydrate Metabolism, Inborn Errors .
C18.452.648.202.449 Glycogen Storage Disease .
C18.452.648.202.449.500 Glycogen Storage Disease Type II .
C18.452.648.595 Lysosomal Storage Diseases .
C18.452.648.595.554 Lysosomal Storage Diseases, Nervous System .
C18.452.648.595.554.340 Glycogen Storage Disease Type II .
D09 Carbohydrates .
D09.400 Glycoconjugates .
D09.400.430 Glycoproteins .
D12 Amino Acids, Peptides, and Proteins .
D12.776 Proteins .
D12.776.124 Blood Proteins .
D12.776.124.117 beta 2-Glycoprotein I .
D12.776.395 Glycoproteins .
D12.776.395.195 beta 2-Glycoprotein I .
D12.776.395.207 Clusterin .
D12.776.395.550 Membrane Glycoproteins .
D12.776.395.550.200 Cell Adhesion Molecules .
D12.776.395.550.200.200 Cadherins .
D12.776.395.550.200.200.500 Desmosomal Cadherins .
D12.776.395.550.200.200.500.500 Desmogleins .
D12.776.395.550.200.200.500.500.625 Desmoglein 2 .
D12.776.395.550.530 Laminin .
D12.776.543 Membrane Proteins .
D12.776.543.550 Membrane Glycoproteins .
D12.776.543.550.200 Cell Adhesion Molecules .
D12.776.543.550.200.200 Cadherins .
D12.776.543.550.200.200.500 Desmosomal Cadherins .
D12.776.543.550.200.200.500.500 Desmogleins .
D12.776.543.550.200.200.500.500.625 Desmoglein 2 .
D12.776.543.550.500 Laminin .
D12.776.580 Molecular Chaperones .
D12.776.580.215 Clusterin .
D12.776.860 Scleroproteins .
D12.776.860.300 Extracellular Matrix Proteins .
D12.776.860.300.675 Laminin .
D23 Biological Factors .
D23.050 Antigens .
D23.050.301 Antigens, Surface .
D23.050.301.350 Cell Adhesion Molecules .
D23.050.301.350.200 Cadherins .
D23.050.301.350.200.500 Desmosomal Cadherins .
D23.050.301.350.200.500.500 Desmogleins .
D23.050.301.350.200.500.500.625 Desmoglein 2 .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Laminin .
Glycoprotein GP-2 .
Laminin M .
Laminin M Chain .
Chain, Laminin M .
Glycoprotein GP 2 .
M Chain, Laminin .
Merosin .
Large, noncollagenous glycoprotein with antigenic properties. It is localized in the basement membrane lamina lucida and functions to bind epithelial cells to the basement membrane. Evidence suggests that the protein plays a role in tumor invasion. .
1.00
9513687
 
Glycoproteins .
Glycoprotein .
Neoglycoproteins .
Conjugated protein-carbohydrate compounds including mucins, mucoid, and amyloid glycoproteins. .
0.67
20067084
 
Clusterin .
ApoJ Protein .
Apolipoprotein J .
Complement Lysis Inhibitor .
Complement-Associated Protein SP-40,40 .
Ionizing Radiation-Induced Protein-8 .
MAC393 Antigen .
SGP-2 Protein .
SP 40,40 Protein .
Sulfated Glycoprotein 2 .
Sulfated Glycoprotein-2 .
TRPM-2 Protein .
Testosterone-Repressed Prostate Message-2 Protein .
X-Ray-Inducible Protein 8 .
XIP8 Protein .
Complement Associated Protein SP 40,40 .
Ionizing Radiation Induced Protein 8 .
Radiation-Induced Protein-8, Ionizing .
SGP 2 Protein .
SP-40,40, Complement-Associated Protein .
TRPM 2 Protein .
Testosterone Repressed Prostate Message 2 Protein .
X Ray Inducible Protein 8 .
A highly conserved heterodimeric glycoprotein that is differentially expressed during many severe physiological disturbance states such as CANCER; APOPTOSIS; and various NEUROLOGICAL DISORDERS. Clusterin is ubiquitously expressed and appears to function as a secreted MOLECULAR CHAPERONE. .
0.65
21749
 
Desmoglein 2 .
Desmoglein II .
Desmosomal Glycoprotein 2 .
A CALCIUM-dependent adhesion molecule of DESMOSOMES that also plays a role in embryonic STEM CELL proliferation. .
0.62
0201
 
Glycogen Storage Disease Type II .
Acid Alpha-Glucosidase Deficiency .
Acid Maltase Deficiency .
Adult Glycogen Storage Disease Type II .
Alpha-1,4-Glucosidase Deficiency .
Deficiency Disease, Acid Maltase .
Deficiency Disease, Lysosomal alpha-1,4-Glucosidase .
Deficiency of Alpha-Glucosidase .
GAA Deficiency .
GSD II .
GSD2 13663 .
Glycogen Storage Disease II .
Glycogen Storage Disease Type 2 .
Glycogen Storage Disease Type II, Adult .
Glycogen Storage Disease Type II, Infantile .
Glycogen Storage Disease Type II, Juvenile .
Glycogenosis Type II .
Infantile Glycogen Storage Disease Type II .
Juvenile Glycogen Storage Disease Type II .
Pompe's Disease .
Acid Alpha Glucosidase Deficiency .
Acid Alpha-Glucosidase Deficiencies .
Acid Maltase Deficiencies .
Alpha 1,4 Glucosidase Deficiency .
Alpha-1,4-Glucosidase Deficiencies .
Alpha-Glucosidase Deficiencies .
Alpha-Glucosidase Deficiencies, Acid .
Alpha-Glucosidase Deficiency .
Alpha-Glucosidase Deficiency, Acid .
Deficiencies, Acid Alpha-Glucosidase .
Deficiencies, Acid Maltase .
Deficiencies, Alpha-1,4-Glucosidase .
Deficiencies, GAA .
Deficiency of Alpha Glucosidase .
Deficiency, Acid Alpha-Glucosidase .
Deficiency, Acid Maltase .
Deficiency, Alpha-1,4-Glucosidase .
Deficiency, GAA .
Disease, Pompe .
Disease, Pompe's .
GAA Deficiencies .
GSD2s .
Generalized Glycogenoses .
Glycogenoses, Generalized .
Glycogenosis, Generalized .
Lysosomal alpha 1,4 Glucosidase Deficiency Disease .
Maltase Deficiencies, Acid .
Pompes Disease .
Type II, Glycogenosis .
Type IIs, Glycogenosis .
Generalized Glycogenosis .
Glycogenosis 2 .
Pompe Disease .
Acid Maltase Deficiency Disease .
Lysosomal alpha-1,4-Glucosidase Deficiency Disease .
POMPE'S DISEASE .
An autosomal recessively inherited glycogen storage disease caused by GLUCAN 1,4-ALPHA-GLUCOSIDASE deficiency. Large amounts of GLYCOGEN accumulate in the LYSOSOMES of skeletal muscle (MUSCLE, SKELETAL); HEART; LIVER; SPINAL CORD; and BRAIN. Three forms have been described: infantile, childhood, and adult. The infantile form is fatal in infancy and presents with hypotonia and a hypertrophic cardiomyopathy (CARDIOMYOPATHY, HYPERTROPHIC). The childhood form usually presents in the second year of life with proximal weakness and respiratory symptoms. The adult form consists of a slowly progressive proximal myopathy. (From Muscle Nerve 1995;3:S61-9; Menkes, Textbook of Child Neurology, 5th ed, pp73-4) .
0.57
361404
 
beta 2-Glycoprotein I .
Anticardiolipin Cofactor .
Apo H .
EC-VMFa .
Endothelial Cell-Viability Maintaining Factor .
beta(2)GPI .
beta2-Glycoprotein I .
Cofactor, Anticardiolipin .
EC VMFa .
Endothelial Cell Viability Maintaining Factor .
beta 2 Glycoprotein I .
beta2 Glycoprotein I .
Apolipoprotein H .
A 44-kDa highly glycosylated plasma protein that binds phospholipids including CARDIOLIPIN; APOLIPOPROTEIN E RECEPTOR; membrane phospholipids, and other anionic phospholipid-containing moieties. It plays a role in coagulation and apoptotic processes. Formerly known as apolipoprotein H, it is an autoantigen in patients with ANTIPHOSPHOLIPID ANTIBODIES. .
0.57
02093